Biomarker-Stratified Phase II Trial of Trastuzumab Rezetecan in Advanced Salivary Gland Carcinoma Across Cohorts With High and Low Human Epidermal Growth Factor Receptor 2 Expression
1. 系统已在2026-09-11 15:35:48对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1200/jco-26-00671
文献链接: https://ascopubs.org/doi/10.1200/JCO-26-00671
其他信息:
出版社: American Society of Clinical Oncology (ASCO)
作者: Guang-Liang Chen; Yanjing Guo; Xin Liu; Ya'nan Yang; Youzhou Sang; Xueguan Lu; Si Sun; Xiao Shi; Yan Zhang; Tong-Zhen Chen; Ning Qu; Duo Wen; Xiao-Shuang Niu; Shu Dong; Yu Wang; Yulong Wang; Jiachen Wang; Lu Zhang; Chaosu Hu; Qinghai Ji; Dongmei Ji

